SEC Form 10-K filed by SELLAS Life Sciences Group Inc.
$SLS
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/21/2021 | $18.00 | Overweight | Cantor Fitzgerald |